# Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms

> **NCT05793957** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 50 (actual)

## Conditions studied

- Hematopoietic and Lymphoid System Neoplasm
- Malignant Breast Neoplasm
- Malignant Head and Neck Neoplasm
- Malignant Solid Neoplasm
- Malignant Thoracic Neoplasm

## Interventions

- **OTHER:** Questionnaire Administration
- **BEHAVIORAL:** Telephone-Based Intervention
- **OTHER:** Virtual Technology Intervention

## Key facts

- **NCT ID:** NCT05793957
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-20
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05793957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05793957, "Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05793957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*